featured
A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
Clin. Cancer Res 2013 Nov 05;[EPub Ahead of Print], JS Ross, K Wang, L Gay, RN Al-Rohil, T Nazeer, CE Sheehan, TA Jennings, G Otto, A Donahue, J He, GA Palmer, S Ali, M Nahas, G Young, E Labrecque, GM Frampton, R Erlich, J Curran, K Brennan, SR Downing, R Yelensky, D Lipson, M Hawryluk, VA Miller, PJ StephensFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.